Jaqueline C Avila1, Silvia Mejia-Arangom2, Daniel Jupiter1,3, Brian Downer4, Rebeca Wong1,5. 1. Department of Preventive Medicine and Population Health, University of Texas Medical Branch, Galveston. 2. Departamento de Estudios de Población, El Colegio de la Frontera Norte, Tijuana, Mexico. 3. Department of Orthopaedic Surgery and Rehabilitation, University of Texas Medical Branch, Galveston. 4. Division of Rehabilitation Sciences, University of Texas Medical Branch, Galveston. 5. Sealy Center on Aging, University of Texas Medical Branch, Galveston.
Abstract
OBJECTIVES: To study the impact of diabetes on the long-term cognitive trajectories of older adults in 2 countries with different socioeconomic and health settings, and to determine whether this relationship differs by cognitive domains. This study uses Mexico and the United States to confirm if patterns hold in both populations, as these countries have similar diabetes prevalence but different socioeconomic conditions and diabetes-related mortality. METHODS: Two nationally representative cohorts of adults aged 50 years or older are used: the Mexican Health and Aging Study for Mexico and the Health and Retirement Study for the United States, with sample sizes of 18,810 and 26,244 individuals, respectively, followed up for a period of 14 years. The outcome is cognition measured as a total composite score and by domain (memory and nonmemory). Mixed-effect linear models are used to test the effect of diabetes on cognition at 65 years old and over time in each country. RESULTS: Diabetes is associated with lower cognition and nonmemory scores at baseline and over time in both countries. In Mexico, diabetes only predicts lower memory scores over time, whereas in the United States it only predicts lower memory scores at baseline. Women have higher total cognition and memory scores than men in both studies. The magnitude of the effect of diabetes on cognition is similar in both countries. DISCUSSION: Despite the overall lower cognition in Mexico and different socioeconomic characteristics, the impact of diabetes on cognitive decline and the main risk and protective factors for poor cognition are similar in both countries.
OBJECTIVES: To study the impact of diabetes on the long-term cognitive trajectories of older adults in 2 countries with different socioeconomic and health settings, and to determine whether this relationship differs by cognitive domains. This study uses Mexico and the United States to confirm if patterns hold in both populations, as these countries have similar diabetes prevalence but different socioeconomic conditions and diabetes-related mortality. METHODS: Two nationally representative cohorts of adults aged 50 years or older are used: the Mexican Health and Aging Study for Mexico and the Health and Retirement Study for the United States, with sample sizes of 18,810 and 26,244 individuals, respectively, followed up for a period of 14 years. The outcome is cognition measured as a total composite score and by domain (memory and nonmemory). Mixed-effect linear models are used to test the effect of diabetes on cognition at 65 years old and over time in each country. RESULTS:Diabetes is associated with lower cognition and nonmemory scores at baseline and over time in both countries. In Mexico, diabetes only predicts lower memory scores over time, whereas in the United States it only predicts lower memory scores at baseline. Women have higher total cognition and memory scores than men in both studies. The magnitude of the effect of diabetes on cognition is similar in both countries. DISCUSSION: Despite the overall lower cognition in Mexico and different socioeconomic characteristics, the impact of diabetes on cognitive decline and the main risk and protective factors for poor cognition are similar in both countries.
Authors: Robert S Wilson; Patricia A Boyle; Lei Yu; Lisa L Barnes; Joel Sytsma; Aron S Buchman; David A Bennett; Julie A Schneider Journal: Neurology Date: 2015-08-26 Impact factor: 9.910
Authors: Kenneth M Langa; Eric B Larson; Jason H Karlawish; David M Cutler; Mohammed U Kabeto; Scott Y Kim; Allison B Rosen Journal: Alzheimers Dement Date: 2008-03-04 Impact factor: 21.566
Authors: Amanda Sonnega; Jessica D Faul; Mary Beth Ofstedal; Kenneth M Langa; John W R Phillips; David R Weir Journal: Int J Epidemiol Date: 2014-03-25 Impact factor: 7.196
Authors: Jessica R Marden; Elizabeth R Mayeda; Eric J Tchetgen Tchetgen; Ichiro Kawachi; M Maria Glymour Journal: Alzheimer Dis Assoc Disord Date: 2017 Jan-Mar Impact factor: 2.703
Authors: Alden L Gross; Dan M Mungas; Paul K Crane; Laura E Gibbons; Anna MacKay-Brandt; Jennifer J Manly; Shubhabrata Mukherjee; Heather Romero; Bonnie Sachs; Michael Thomas; Guy G Potter; Richard N Jones Journal: Psychol Aging Date: 2015-11-02
Authors: Geert Jan Biessels; Salka Staekenborg; Eric Brunner; Carol Brayne; Philip Scheltens Journal: Lancet Neurol Date: 2006-01 Impact factor: 44.182
Authors: Silvia Mejia-Arango; Jaqueline Avila; Brian Downer; Marc A Garcia; Alejandra Michaels-Obregon; Joseph L Saenz; Rafael Samper-Ternent; Rebeca Wong Journal: Geriatrics (Basel) Date: 2021-06-25